Teicoplanin therapy for Staphylococcus aureus septicaemia: relationship between pre-dose serum concentrations and outcome

J Antimicrob Chemother. 2000 Jun;45(6):835-41. doi: 10.1093/jac/45.6.835.

Abstract

Logistic regression analysis was performed on data drawn from a clinical trials database for Staphylococcus aureus septicaemia treated with teicoplanin. Variables analysed were age, body weight, mean pre-dose and post-dose serum teicoplanin concentrations, mean dose (mg or mg/kg body weight) and combination versus monotherapy. Only two variables correlated with clinical outcome at a significance level better than 0.05: age (P = 0.012) and mean pre-dose serum concentration (P = 0.010). The probability of successful treatment declined with age and increased with mean pre-dose serum concentration.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Algorithms
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / blood
  • Anti-Bacterial Agents / therapeutic use*
  • Body Weight
  • Humans
  • Logistic Models
  • Microbial Sensitivity Tests
  • Middle Aged
  • Sepsis / drug therapy*
  • Sepsis / epidemiology
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / epidemiology
  • Teicoplanin / administration & dosage
  • Teicoplanin / blood
  • Teicoplanin / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Teicoplanin